title: Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice.
abstract: Malignant pleural mesothelioma (MPM) is a rare cancer that is refractory to current treatments. It is characterized by a robust deposition of transitional fibrin that is in part promoted by tumor cells. MPM cells express tissue factor (TF) and the tissue factor pathway inhibitor (TFPI), but their contribution to the pathogenesis of MPM has been unclear. We found that REN MPM cells fail to express TFPI. Based on the tumor growth-promoting properties of TF, we hypothesized that the stable transfection of TFPI into REN MPM cells would decrease their aggressiveness. We tested our hypothesis using in vitro, in vivo, and ex vivo analyses. TFPI knock-in decreased the proliferation, invasion, and TF activity of REN cells in vitro. REN TFPI knock-in cells, empty vector, and naive control cells were next injected intrapleurally into nude mice. The expression of TFPI significantly decreased tissue invasion, inflammation, and the deposition of fibrin and collagen associated with tumor tissue, pleural effusions, and tumor burden. In ex vivo analyses, REN cells were cultured from harvested tumors. The overexpression of TFPI was maintained in cells propagated from TFPI knock-in tumors, and attenuated the activation of Factor X and the invasiveness of tumor cells. These analyses demonstrate that TFPI reduces the aggressiveness of MPM in vitro and in vivo, and that its effect involves the inhibition of TF procoagulant activity. These observations suggest that the interactions of TF and TFPI represent a novel therapeutic target in the treatment of MPM.
authors.affiliation: Texas Lung Injury Institute, University of Texas Health Science Center at Tyler, 11937 US Highway 271, Biomedical Research Building, Laboratory C-5, Tyler, TX 75708, USA.
authors.forename: LaTerrica
authors.initials: L
authors.lastname: Williams
authors.forename: Torry A
authors.initials: TA
authors.lastname: Tucker
authors.forename: Kathy
authors.initials: K
authors.lastname: Koenig
authors.forename: Timothy
authors.initials: T
authors.lastname: Allen
authors.forename: L Vijaya Mohan
authors.initials: LV
authors.lastname: Rao
authors.forename: Usha
authors.initials: U
authors.lastname: Pendurthi
authors.forename: Steven
authors.initials: S
authors.lastname: Idell
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism; D018450:Disease Progression; D008074:Lipoproteins / Q000502:physiology*; D008654:Mesothelioma / Q000473:pathology / Q000517:prevention & control*; D051379:Mice; D008819:Mice, Nude; D010997:Pleural Neoplasms / Q000473:pathology / Q000517:prevention & control*
chemical_list: D014408:Biomarkers, Tumor; D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor